| Date | Form | Description | Docs | XBRL | Pages |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/15/12 | CT ORDER | Confidential treatment order |
|
1 | |
| 11/08/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 11/08/12 | 8-K | Current report filing |
|
20 | |
| 11/06/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 10/29/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 10/12/12 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
52 | |
| 10/10/12 | 8-K | Current report filing |
|
20 | |
| 10/10/12 | 8-K | Current report filing |
|
3 | |
| 10/02/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
Read More...